1. Home
  2. IMMR vs TNYA Comparison

IMMR vs TNYA Comparison

Compare IMMR & TNYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Immersion Corporation

IMMR

Immersion Corporation

HOLD

Current Price

$6.28

Market Cap

207.5M

Sector

Technology

ML Signal

HOLD

Logo Tenaya Therapeutics Inc.

TNYA

Tenaya Therapeutics Inc.

HOLD

Current Price

$0.79

Market Cap

171.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
IMMR
TNYA
Founded
1993
2016
Country
United States
United States
Employees
8
70
Industry
Computer peripheral equipment
Medicinal Chemicals and Botanical Products
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
207.5M
171.4M
IPO Year
1999
2021

Fundamental Metrics

Financial Performance
Metric
IMMR
TNYA
Price
$6.28
$0.79
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
3
Target Price
$13.50
$5.33
AVG Volume (30 Days)
461.6K
4.7M
Earning Date
04-13-2026
05-07-2026
Dividend Yield
5.11%
N/A
EPS Growth
N/A
54.96
EPS
0.02
N/A
Revenue
$35,013,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$303.75
N/A
Revenue Growth
N/A
N/A
52 Week Low
$5.25
$0.43
52 Week High
$8.15
$2.35

Technical Indicators

Market Signals
Indicator
IMMR
TNYA
Relative Strength Index (RSI) 52.74 47.05
Support Level $5.78 $0.65
Resistance Level $6.39 $0.82
Average True Range (ATR) 0.24 0.09
MACD -0.03 -0.01
Stochastic Oscillator 44.01 7.60

Price Performance

Historical Comparison
IMMR
TNYA

About IMMR Immersion Corporation

Immersion Corp is focused on the creation, design, development, and licensing of haptic technologies that allow people to use its sense of touch more fully as it involves engaging with products and experience the digital world. The company's software focuses on applications in mobile devices, wearables, consumer, and gaming devices markets. It generates revenue from royalty and license fees, and development contract and service fees. Geographically, the company generates a majority of its revenue from Japan, followed by Korea, Germany, United States of America and other countries.

About TNYA Tenaya Therapeutics Inc.

Tenaya Therapeutics Inc is a clinical-stage biotechnology company focused on the discovery and development of therapies targeting the underlying mechanisms of heart disease. It is developing therapies for rare genetic disorders as well as for more prevalent heart conditions through three distinct but interrelated product platforms: Gene Therapy, Cellular Regeneration and Precision Medicine. The company's clinical-stage gene therapy candidates include TN-201 and TN-401. It operates in one operating segment, which is the business of discovering and developing potential treatments that address the underlying drivers of heart disease.

Share on Social Networks: